Outcomes | Total | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | P |
---|---|---|---|---|---|---|---|
3Â months: | |||||||
 Mortality | 340 (5.4) | 76 (6.2) | 57 (4.6) | 54 (4.3) | 73 (5.7) | 80 (6.5) | 0.414 |
 Dependency | 602 (10.1) | 124 (10.7) | 125 (10.3) | 108 (8.9) | 111 (9.1) | 134 (11.4) | 0.962 |
 Recurrence | 207 (8.5) | 81 (7.0) | 90 (7.4) | 118 (9.8) | 118 (9.7) | 100 (8.6) | 0.038 |
12Â months: | |||||||
 Mortality | 454 (8.3) | 91 (8.6) | 87 (7.9) | 68 (6.3) | 94 (8.4) | 114 (10.6) | 0.080 |
 Dependency | 1218 (24.4) | 258 (26.6) | 239 (23.4) | 234 (22.9) | 250 (24.4) | 237 (24.7) | 0.538 |
 Recurrence | 1153 (22.7) | 229 (23.3) | 219 (20.9) | 261 (25.4) | 229 (22.0) | 215 (21.8) | 0.647 |
36Â months: | |||||||
 Mortality | 588 (15.8) | 109 (15.5) | 127 (16.1) | 103 (13.6) | 117 (15.9) | 132 (18.2) | 0.229 |
 Dependency | 1447 (46.2) | 305 (51.2) | 301 (45.4) | 290 (44.1) | 282 (45.5) | 269 (45.2) | 0.070 |
 Recurrence | 1359 (40.7) | 294 (46.3) | 291 (41.0) | 289 (41.1) | 249 (37.7) | 236 (37.3) | 0.001 |